Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis

69Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Influenza-related severe pneumonia and acute respiratory distress syndrome (ARDS) are severe threats to human health. The objective of this study was to assess the effects of systematic corticosteroid therapy in patients with pneumonia or ARDS. The PubMed, EMBASE, Web of Science and SCOPUS databases were searched up to July, 2019. Nineteen studies including 6637 individuals were identified, and fifteen studies (6427 patients) were included in the meta-analysis of mortality. Eighteen were observational studies and one was a randomized controlled trial (RCT). The meta-analysis results showed that corticosteroid therapy was associated with significantly higher mortality (OR 1.53, 95% CI [1.16, 2.01]) and incidence of nosocomial infection (OR 3.15, 95% CI [1.54, 6.45]). Subgroup analysis showed that among patients with unadjusted estimates, the odds of mortality were higher in patients receiving corticosteroid treatment (OR 1.98, 95% CI [1.23, 3.17]), however, among patients with adjusted estimates, the result showed no statistically significant difference between corticosteroid group and control group (OR 1.31, 95% CI [0.95, 1.80]). Current data do not support the routine use of corticosteroids in patients with influenza severe pneumonia or ARDS. RCTs are needed to provide more robust evidence.

References Powered by Scopus

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

12735Citations
N/AReaders
Get full text

Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012

4809Citations
N/AReaders
Get full text

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

4769Citations
N/AReaders
Get full text

Cited by Powered by Scopus

COVID-19 vaccines: The status and perspectives in delivery points of view

263Citations
N/AReaders
Get full text

Influenza

205Citations
N/AReaders
Get full text

Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis

150Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhou, Y., Fu, X., Liu, X., Huang, C., Tian, G., Ding, C., … Yang, S. (2020). Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-59732-7

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 28

68%

Lecturer / Post doc 6

15%

Researcher 6

15%

Professor / Associate Prof. 1

2%

Readers' Discipline

Tooltip

Medicine and Dentistry 33

75%

Biochemistry, Genetics and Molecular Bi... 5

11%

Agricultural and Biological Sciences 4

9%

Pharmacology, Toxicology and Pharmaceut... 2

5%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free